56 reports

Tuberculosis (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Drugs In Development, 2021, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape.Tuberculosis, commonly known as TB, is...

  • Tuberculosis
  • Drug Development
  • World
  • South Africa
  • India
  • Drug Approval
  • Stem Cell Transplantation

Tuberculosis - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Pipeline Review, H2 2020, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape. Tuberculosis, commonly known as TB, is a bacterial infection...

  • Tuberculosis
  • World
  • Drug Approval
  • Stem Cell Transplantation

Mycobacterium Tuberculosis Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Mycobacterium Tuberculosis Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Mycobacterium Tuberculosis Tests pipeline products with...

  • Tuberculosis
  • World
  • India
  • United Kingdom
  • Nigeria
  • Tuberculosis Prevalence
  • Medical Devices Sales

Tuberculosis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis – Pipeline Review, H1 2020, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape. Tuberculosis, commonly known as TB, is a bacterial...

  • Tuberculosis
  • Stem Cell Transplantation
  • Prescription Drug Sales

China’s demand for Tuberculosis Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Tuberculosis
  • Anti-Infective
  • China
  • Prescription Drug Sales
  • Industrial Production

Mycobacterium Tuberculosis Infections (Infectious Disease) - Drugs in Development, 2021 Summary Mycobacterium Tuberculosis Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Mycobacterium Tuberculosis Infections pipeline landscape. The report provides...

  • Tuberculosis
  • Infectious Disease
  • World

Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021 Summary Mycobacterium tuberculosis Protein Ag85A - Drugs in Development, 2021 provides in depth analysis on Mycobacterium tuberculosis Protein Ag85A targeted pipeline therapeutics. The report provides comprehensive information...

  • Tuberculosis
  • World

The global tuberculosis diagnostics market is expected to exhibit moderate growth during 2021-2026. Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test...

  • Diagnostics
  • Tuberculosis
  • World
  • Health Expenditure

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Drugs in Development, 2021 Summary Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Drugs in Development, 2021 provides in depth analysis on Mycobacterium...

  • Tuberculosis
  • World

2021 Global Tuberculosis (TB) Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies , Latest Instrumentation, Opportunities for Suppliers This unique report provides information and analysis not available from any other published source.The report...

  • Tuberculosis
  • Diagnostics
  • World
  • Europe

The global latent TB detection market is expected to reach US$ 1,684.86 million in 2027 from US$ 1,131.82 million in 2019. The market is estimated to grow with a CAGR of 5.2% from 2020-2027. The growth of the market is attributed to some key driving factors such as increasing prevalence of tuberculosis and government initiatives to...

  • Tuberculosis
  • APAC
  • World
  • Tuberculosis Prevalence
  • Tuberculosis Incidence

2022-2026 Global Tuberculosis (TB) Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation This report is available by geographic region and country. Geographic Regions and Countries Asia-Pacific Australia,...

  • Tuberculosis
  • Diagnostics
  • Europe
  • Northern Europe
  • Asia
  • Latin America
  • World
  • Mexico
  • China

Succeeding in the 2020 Global Tuberculosis (TB) Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe...

  • Tuberculosis
  • Europe
  • World
  • United States

H+ Transporting Two Sector ATPase - Pipeline Review, H1 2020 Summary According to the recently published report ’H+ Transporting Two Sector ATPase - Pipeline Review, H1 2020’; H+ Transporting Two Sector ATPase (F1F0 ATP Synthase or ATP Synthase or Mitochondrial ATPase or Bacterial Ca2+/Mg2+ ATPase...

  • Tuberculosis
  • Pharmaceutical
  • World
  • Drug Approval
  • Health Provider Density

H+ Transporting Two Sector ATPase - Pipeline Review, H2 2019 Summary H+ Transporting Two Sector ATPase (F1F0 ATP Synthase or ATP Synthase or Mitochondrial ATPase or Bacterial Ca2+/Mg2+ ATPase or EC 7.1.2.2) pipeline Target constitutes close to 6 molecules. Out of which approximately 4 molecules are...

  • Tuberculosis
  • Pharmaceutical
  • World
  • Drug Approval
  • Health Provider Density

Mycobacterium Tuberculosis Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Mycobacterium Tuberculosis Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market...

  • Tuberculosis
  • World

2020 Tuberculosis (TB) Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies , Latest Instrumentation, Opportunities for Suppliers The report presents a detailed analysis of the Vibrio diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current...

  • Diagnostics
  • Tuberculosis
  • Europe
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

The global latent tuberculosis infection (LTBI) testing market is estimated to reach US$2.20 billion in 2025, witnessing growth at a CAGR of 5.89% for the period spanning from 2021 to 2025. The factors such as increase in ageing population, rising awareness of tuberculosis, upsurge in cigarette consumption, urbanization leading to monitoring...

  • Tuberculosis
  • World
  • Health Expenditure
  • HIV AIDS Prevalence

This study focuses on China’s Tuberculosis Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Tuberculosis
  • Anti-Infective
  • China
  • Prescription Drug Sales
  • Employment Costs

This study focuses on China’s Tuberculosis Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Tuberculosis
  • China
  • Prescription Drug Sales
  • Labour Force

Market Overview The anti-tuberculosis therapeutics market is expected to witness a CAGR of approximately 6.0% over the forecast period, 2019-2024. - Factors, such as the rising prevalence of tuberculosis, a growing initiative from government organization for tuberculosis awareness, a collaboration between academic...

  • Tuberculosis
  • World
  • Spending On Medicines
  • Health Expenditure

Succeeding in the Global Tuberculosis (TB) Testing Market, 2019-2023: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities The report presents a detailed analysis of the Tuberculosis diagnostics market in the...

  • Tuberculosis
  • Europe
  • World
  • United States

The Asia Pacific Mechanical Ventilator Market would witness market growth of 14.5% CAGR during the forecast period (2021-2027). The market is moving towards saturation as various manufacturers have sped up their production capacities to meet the existing demand and there will be ample availability of ventilators post covid-19 situation....

  • Intensive Care
  • Respiratory Monitoring
  • Tuberculosis
  • APAC
  • China
  • India
  • Chronic Disease Prevalence

Summary Biological Dynamics Inc (Biological Dynamics) operates as a molecular diagnostics company.The company’s proprietary lab-on-a-chip (LOC) platform, Verita utilizes AC electrokinetics (ACE) technology for isolation of nanoparticles and macromolecules from biofluids includes whole blood, plasma and serum. It...

  • Diagnostics
  • Clinical Trial
  • Tuberculosis
  • World
  • Medical Devices Sales

Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems.The company provides product such as nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray readers and software. Its...

  • Diagnostics
  • Tuberculosis
  • In Vitro Diagnostic Reagent
  • Clinical Trial
  • United States
  • World
  • North America
  • Mental Health Providers Density
  • Drug Approval

2019-2023 Competing in the Global Tuberculosis (TB) Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities The report presents a detailed analysis of the Tuberculosis diagnostics market in the US,...

  • Tuberculosis
  • Europe
  • World
  • United States

The ongoing clinical trial research report- “2019 Mycobacterium tuberculosis Infections Ongoing Clinical Trials Study” analyzes the current scenario of all active Mycobacterium tuberculosis Infections trials across the world. The report presents top level analysis of global Mycobacterium tuberculosis Infections clinical trials across countries,...

  • Tuberculosis
  • Clinical Trial
  • World
  • APAC

The global latent tuberculosis infection (LTBI) testing market is estimated to reach US$2.1 billion in 2023, growing at a CAGR of 5.59% for the period spanning from 2018 to 2023. The factors such as rapid tuberculosis prevalence, increased tuberculosis awareness, rising prevalence of HIV and increasing government initiatives are expected to...

  • Tuberculosis
  • World
  • Health Expenditure
  • Tuberculosis Prevalence

Global Tuberculosis (TB) Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023 The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain,...

  • Tuberculosis
  • Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

2019 Global Tuberculosis (TB) Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK)...

  • Tuberculosis
  • Diagnostics
  • World
  • Europe